Interactions of antimicrobial peptides with Leishmania and trypanosomes and their functional role in host parasitism

Experimental Parasitology

Volumn 126, Issue 3, 2010, Pages 397-405

  McGwire, Bradford S ^a   Kulkarni, Manjusha M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Antimicrobial peptides; Host parasite interactions; Leishmania; Trypanosoma brucei; Trypanosoma cruzi

Indexed keywords

ATTACIN; CATHELICIDIN; CECROPIN A; DEFENSIN; MYTILIN; POLYPEPTIDE ANTIBIOTIC AGENT; TEMPORIN A; TEMPORIN B; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE;

AMASTIGOTE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; DIFFERENTIATION; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; INTRACELLULAR KILLING; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIASIS; MITOCHONDRIAL TOXICITY; NONHUMAN; PARASITE TRANSMISSION; PARASITE VECTOR; PARASITISM; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; ANIMAL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INNATE IMMUNITY; INSECT; KINETOPLASTIDA; LIFE CYCLE STAGE; PARASITOLOGY; PHYSIOLOGY; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMATID INFECTION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; EUGLENOZOA INFECTIONS; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNITY, INNATE; INSECTS; LEISHMANIA; LIFE CYCLE STAGES; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMA CRUZI; TRYPANOSOMATINA;

HEXAPODA; MAMMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI; TRYPANOSOMATIDAE;

EID: 77956255464     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.02.006     Document Type: Article

References (66)

1. Abbassi F., Oury B., Blasco T., Sereno D., Bolbach G., Nicolas P., Hani K., Amiche M., Ladram A. Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica. Peptides 2008, 29:1526-1533.
2. Akuffo H., Hultmark D., Engstom A., Frohlich D., Kimbrell D. Drosophila antibacterial protein, cecropin A, differentially affects non-bacterial organisms such as Leishmania in a manner different from other amphipathic peptides. International Journal of Molecular Medicine 1998, 1:77-82.
3. Alberola J., Rodriguez A., Francino O., Roura X., Rivas L., Andreu D. Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis. Antimicrobial Agents & Chemotherapy 2004, 48:641-643.
4. Amino R., Martins R.M., Procopio J., Hirata I.Y., Juliano M.A., Schenkman S. Trialysin, a novel pore-forming protein from saliva of hematophagous insects activated by limited proteolysis. Journal of Biological Chemistry 2002, 277:6207-6213.
5. Andrews N.W., Abrams C.K., Slatin S.L., Griffiths G. A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH. Cell 1990, 61:1277-1287.
6. Barr S.C., Rose D., Jaynes J.M. Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemias in mice. Journal of Parasitology 1995, 81:974-978.
7. Beard C.B., Cordon-Rosales C., Durvasula R.V. Bacterial symbionts of the triatominae and their potential use in control of Chagas disease transmission. Annual Review of Entomology 2002, 47:123-141.
8. Beard C.B., Dotson E.M., Pennington P.M., Eichler S., Cordon-Rosales C., Durvasula R.V. Bacterial symbiosis and paratransgenic control of vector-borne Chagas disease. International Journal of Parasitology 2001, 31:621-627.
9. Bera A., Singh S., Nagaraj R., Vaidya T. Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides. Molecular & Biochemical Parasitology 2003, 127:23-35.
10. Berrocal-Lobo M., Molina A., Rodriguez-Palenzuela P., Garcia-Olmedo F., Rivas L. Leishmania donovani: thionins, plant antimicrobial peptides with leishmanicidal activity. Experimental Parasitology 2009, 122:247-249.
11. Boulanger N., Bulet P., Lowenberger C. Antimicrobial peptides in the interactions between insects and flagellate parasites. Trends in Parasitology 2006, 22:262-268.
12. Boulanger N., Lowenberger C., Volf P., Ursic R., Sigutova L., Sabatier L., Svobodova M., Beverley S.M., Spath G., Brun R., Pesson B., Bulet P. Characterization of a defensin from the sand fly Phlebotomus duboscqi induced by challenge with bacteria or the protozoan parasite Leishmania major. Infection & Immunity 2004, 72:7140-7146.
13. Braff M.H., Hawkins M.A., Di Nardo A., Lopez-Garcia B., Howell M.D., Wong C., Lin K., Streib J.E., Dorschner R., Leung D.Y., Gallo R.L. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. Journal of Immunology 2005, 174:4271-4278.
14. Brand G.D., Leite J.R., de Sa Mandel S.M., Mesquita D.A., Silva L.P., Prates M.V., Barbosa E.A., Vinecky F., Martins G.R., Galasso J.H., Kuckelhaus S.A., Sampaio R.N., Furtado J.R., Andrade A.C., Bloch C. Novel dermaseptins from Phyllomedusa hypochondrialis (Amphibia). Biochemical and Biophysical Research Communications 2006, 347:739-746.
15. Brand G.D., Leite J.R., Silva L.P., Albuquerque S., Prates M.V., Azevedo R.B., Carregaro V., Silva J.S., Sa V.C., Brandao R.A., Bloch C. Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells. Journal of Biological Chemistry 2002, 277:49332-49340.
16. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nature Reviews of Microbiology 2005, 3:238-250.
17. Castro M.S., Fontes W. Plant defense and antimicrobial peptides. Protein and Peptide Letters 2005, 12:13-18.
18. Chicharro C., Granata C., Lozano R., Andreu D., Rivas L. N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide. Antimicrobial Agents & Chemotherapy 2001, 45:2441-2449.
19. Contreras V.T., Araujo-Jorge T.C., Bonaldo M.C., Thomaz N., Barbosa H.S., Meirelles Mde N., Goldenberg S. Biological aspects of the Dm 28c clone of Trypanosoma cruzi after metacyclogenesis in chemically defined media. Memorial Institute Oswaldo Cruz 1988, 83:123-133.
20. Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee, 1998. World Health Organ Technical Report Series, vol. 881, pp. 1-114.
21. Diaz-Achirica P., Ubach J., Guinea A., Andreu D., Rivas L. The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide. Biochemical Journal 1998, 330(Pt. 1):453-460.
22. Durvasula R.V., Gumbs A., Panackal A., Kruglov O., Aksoy S., Merrifield R.B., Richards F.F., Beard C.B. Prevention of insect-borne disease: an approach using transgenic symbiotic bacteria. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:3274-3278.
23. Ganz T., Lehrer R.I. Defensins. Current Opinion in Immunology 1994, 6:584-589.
24. Garcia E.S., Gonzalez M.S., de Azambuja P., Baralle F.E., Fraidenraich D., Torres H.N., Flawia M.M. Induction of Trypanosoma cruzi metacyclogenesis in the gut of the hematophagous insect vector, Rhodnius prolixus, by hemoglobin and peptides carrying alpha d-globin sequences. Experimental Parasitology 1995, 81:255-261.
25. Gonzalez-Rey E., Chorny A., Delgado M. VIP: an agent with license to kill infective parasites. Annals of the New York Academy of Sciences 2006, 1070:303-308.
26. Grandgenett P.M., Coughlin B.C., Kirchhoff L.V., Donelson J.E. Differential expression of GP63 genes in Trypanosoma cruzi. Molecular & Biochemical Parasitology 2000, 110:409-415.
27. Guerrero E., Saugar J.M., Matsuzaki K., Rivas L. Role of positional hydrophobicity in the leishmanicidal activity of magainin 2. Antimicrobial Agents & Chemotherapy 2004, 48:2980-2986.
28. Haines L.R., Thomas J.M., Jackson A.M., Eyford B.A., Razavi M., Watson C.N., Gowen B., Hancock R.E., Pearson T.W. Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18. PLoS Neglected Tropical Diseases 2009, 3:e373.
29. Hancock R.E., Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends in Microbiology 2000, 8:402-410.
30. Hao Z., Kasumba I., Lehane M.J., Gibson W.C., Kwon J., Aksoy S. Tsetse immune responses and trypanosome transmission: implications for the development of tsetse-based strategies to reduce trypanosomiasis. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:12648-12653.
31. Hernandez C., Mor A., Dagger F., Nicolas P., Hernandez A., Benedetti E.L., Dunia I. Functional and structural damage in Leishmania mexicana exposed to the cationic peptide dermaseptin. European Journal of Cell Biology 1992, 59:414-424.
32. Hu C., Aksoy S. Innate immune responses regulate trypanosome parasite infection of the tsetse fly Glossina morsitans morsitans. Molecular Microbiology 2006, 60:1194-1204.
33. Hu Y., Aksoy S. An antimicrobial peptide with trypanocidal activity characterized from Glossina morsitans morsitans. Insect Biochemistry and Molecular Biology 2005, 35:105-115.
34. Huang C.M., Chen H.C., Zierdt C.H. Magainin analogs effective against pathogenic protozoa. Antimicrobial Agents and Chemotherapy 1990, 34:1824-1826.
35. Izadpanah A., Gallo R.L. Antimicrobial peptides. Journal of the American Academy of Dermatology 2005, 52:381-390. quiz 391-382.
36. Jacobs T., Bruhn H., Gaworski I., Fleischer B., Leippe M. NK-lysin and its shortened analog NK-2 exhibit potent activities against Trypanosoma cruzi. Antimicrobial Agents and Chemotherapy 2003, 47:607-613.
37. Jaynes J.M., Burton C.A., Barr S.B., Jeffers G.W., Julian G.R., White K.L., Enright F.M., Klei T.R., Laine R.A. In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi. FASEB Journal 1988, 2:2878-2883.
38. Kitani H., Naessens J., Kubo M., Nakamura Y., Iraqi F., Gibson J., Yamakawa M. Synthetic nonamer peptides derived from insect defensin mediate the killing of African trypanosomes in axenic culture. Parasitology Research 2009, 105:217-225.
39. Kuckelhaus S.A., Leite J.R., Muniz-Junqueira M.I., Sampaio R.N., Bloch C., Tosta C.E. Antiplasmodial and antileishmanial activities of phylloseptin-1, an antimicrobial peptide from the skin secretion of Phyllomedusa azurea (Amphibia). Experimental Parasitology 2009, 123:11-16.
40. Kulkarni M.M., McMaster W.R., Kamysz E., Kamysz W., Engman D.M., McGwire B.S. The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing. Molecular Microbiology 2006, 62:1484-1497.
41. Kulkarni M.M., McMaster W.R., Kamysz W., McGwire B.S. Antimicrobial peptide-induced apoptotic death of Leishmania results from calcium-dependent, caspase-independent mitochondrial toxicity. Journal of Biological Chemistry 2009, 284:15496-15504.
42. Kulkarni M.M., Olson C.L., Engman D.M., McGwire B.S. Trypanosoma cruzi GP63 proteins undergo stage-specific differential posttranslational modification and are important for host cell infection. Infection & Immunity 2009, 77:2193-2200.
43. Lofgren S.E., Miletti L.C., Steindel M., Bachere E., Barracco M.A. Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals. Experimental Parasitology 2008, 118:197-202.
44. Luque-Ortega J.R., Rivero-Lezcano O.M., Croft S.L., Rivas L. In vivo monitoring of intracellular ATP levels in Leishmania donovani promastigotes as a rapid method to screen drugs targeting bioenergetic metabolism. Antimicrobial Agents & Chemotherapy 2001, 45:1121-1125.
45. Luque-Ortega J.R., Saugar J.M., Chiva C., Andreu D., Rivas L. Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular ATP. Biochemical Journal 2003, 375:221-230.
46. Luque-Ortega J.R., van't Hof W., Veerman E.C., Saugar J.M., Rivas L. Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in Leishmania. FASEB Journal 2008, 22:1817-1828.
47. Mangoni M.L., Papo N., Saugar J.M., Barra D., Shai Y., Simmaco M., Rivas L. Effect of natural l- to d-amino acid conversion on the organization, membrane binding, and biological function of the antimicrobial peptides bombinins H. Biochemistry 2006, 45:4266-4276.
48. Mangoni M.L., Saugar J.M., Dellisanti M., Barra D., Simmaco M., Rivas L. Temporins, small antimicrobial peptides with leishmanicidal activity. Journal of Biological Chemistry 2005, 280:984-990.
49. Martins R.M., Amino R., Daghastanli K.R., Cuccovia I.M., Juliano M.A., Schenkman S. A short proregion of trialysin, a pore-forming protein of Triatoma infestans salivary glands, controls activity by folding the N-terminal lytic motif. FEBS Letters 2008, 275:994-1002.
50. Martins R.M., Sforca M.L., Amino R., Juliano M.A., Oyama S., Juliano L., Pertinhez T.A., Spisni A., Schenkman S. Lytic activity and structural differences of amphipathic peptides derived from trialysin. Biochemistry 2006, 45:1765-1774.
51. McGwire B.S., Olson C.L., Tack B.F., Engman D.M. Killing of African trypanosomes by antimicrobial peptides. Journal of Infectious Diseases 2003, 188:146-152.
52. Mor A., Nicolas P. Isolation and structure of novel defensive peptides from frog skin. European Journal of Biochemistry 1994, 219:145-154.
53. Moreno S.N., Docampo R. Calcium regulation in protozoan parasites. Current Opinions in Microbiology 2003, 6:359-364.
54. Nizet V., Ohtake T., Lauth X., Trowbridge J., Rudisill J., Dorschner R.A., Pestonjamasp V., Piraino J., Huttner K., Gallo R.L. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001, 414:454-457.
55. Noronha F.S., Cruz J.S., Beirao P.S., Horta M.F. Macrophage damage by Leishmania amazonensis cytolysin: evidence of pore formation on cell membrane. Infection & Immunity 2000, 68:4578-4584.
56. Roch P., Beschin A., Bernard E. Antiprotozoan and antiviral activities of non-cytotoxic truncated and variant analogues of mussel defensin. Evidence Based Complementary Alternative Medicine 2004, 1:167-174.
57. Rosenberger C.M., Gallo R.L., Finlay B.B. Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2422-2427.
58. Savoia D., Guerrini R., Marzola E., Salvadori S. Synthesis and antimicrobial activity of dermaseptin S1 analogues. Bioorganic & Medicinal Chemistry 2008, 16:8205-8209.
59. Silva P.I., Daffre S., Bulet P. Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family. Journal of Biological Chemistry 2000, 275:33464-33470.
60. Ursic-Bedoya R.J., Lowenberger C.A. Rhodnius prolixus: identification of immune-related genes up-regulated in response to pathogens and parasites using suppressive subtractive hybridization. Developmental & Comparative Immunology 2007, 31:109-120.
61. van Zandbergen G., Bollinger A., Wenzel A., Kamhawi S., Voll R., Klinger M., Muller A., Holscher C., Herrmann M., Sacks D., Solbach W., Laskay T. Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:13837-13842.
62. Waniek P.J., Castro H.C., Sathler P.C., Miceli L., Jansen A.M., Araujo C.A. Two novel defensin-encoding genes of the Chagas disease vector Triatoma brasiliensis (Reduviidae, Triatominae): gene expression and peptide-structure modeling. Journal of Insect Physiology 2009, 55:840-848.
63. World Health Organization action in Afghanistan aims to control debilitating leishmaniasis, 2004. Available from: <>. http://www.who.int/mediacentre/news/releases/2004/pr55/en/print.html.
64. World Health Organization, T.R.S., 1991. Control of Chagas disease, pp. 1-95.
65. Yamasaki K., Di Nardo A., Bardan A., Murakami M., Ohtake T., Coda A., Dorschner R.A., Bonnart C., Descargues P., Hovnanian A., Morhenn V.B., Gallo R.L. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nature Medicine 2007, 13:975-980.
66. Zampa M.F., Araujo I.M., Costa V., Nery Costa C.H., Santos J.R., Zucolotto V., Eiras C., Leite J.R. Leishmanicidal activity and immobilization of dermaseptin 01 antimicrobial peptides in ultrathin films for nanomedicine applications. Nanomedicine 2009, 5:352-358.